Dual versus single antiplatelet therapy after lower extremity revascularization in peripheral artery disease: A systematic review and meta-analysis

Figure 1  Preferred Reporting Items for Systematic Reviews and Meta-Analyses flowchart outlining the literature screening process, study selection, and exclusion criteria.

Figure 2 Forest plots of pooled risk ratios for clinical outcomes comparing dual antiplatelet therapy vs single antiplatelet therapy in patients with peripheral artery disease undergoing lower extremity revascularization. A: All-cause mortality; B: Cardiac mortality; C: Myocardial infarction; D: Stroke; E: Major reintervention; F: Bleeding.